Article Details
Retrieved on: 2022-07-22 12:01:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Biosimilar Monoclonal Antibodies (mAbs) Market size is valued at USD 4100 Million in 2021 and projected to USD 14300 Million by 2030, ...
Article found on: www.einnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here